Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers.

Creative Commons License

Oztop I., Gencer M., Okan T., Yaren A., Altekin E., Turker S., ...Daha Fazla

Japanese journal of clinical oncology, cilt.34, sa.5, ss.262-8, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 5
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1093/jjco/hyh047
  • Dergi Adı: Japanese journal of clinical oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.262-8
  • Anahtar Kelimeler: 5-fluorouracil, cardiotoxicity, echocardiography, troponin I, QT dispersion, SYMPTOMATIC CARDIOTOXICITY, MYOCARDIAL INJURY, CARDIAC DEATH, FOLINIC ACID, FOLLOW-UP, MORTALITY, PROLONGATION, RISK, REPOLARIZATION, CHEMOTHERAPY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: To evaluate the cardiotoxicity of LV5FU2 regimen (bolus plus infusional 5-fluorouracil/folinic acid) treatment by non-invasive methods such as echocardiography, plasma troponin I (TnI) level, QT interval and QT dispersion on ECG.